Blockade of Exosome Release Sensitizes Breast Cancer to Doxorubicin via Inhibiting Angiogenesis

Together, we here revealed that cancer-derived exosomes promote angiogenesis during cancer progression and GW4869 treatment would sensitize the cancer cells to doxorubicin at least partially via inhibiting angiogenesis.

Authors

Institutions

Publication Details

Journal
Cancer Medicine
Published
2025-04-01
DOI
https://doi.org/10.1002/cam4.70785
Citations
2
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blockade of Exosome Release Sensitizes Breast Cancer to Doxorubicin via Inhibiting Angiogenesis

Qin Yang, Fengyi He, Jindi He, Qiuyun Li
2 citations
Cancer Medicine
Extracellular vesicles in disease
1.61
article

Blockade of Exosome Release Sensitizes Breast Cancer to Doxorubicin via Inhibiting Angiogenesis

Qin Yang, Fengyi He, Jindi He, Qiuyun Li
article en
2 citations

Abstract

Together, we here revealed that cancer-derived exosomes promote angiogenesis during cancer progression and GW4869 treatment would sensitize the cancer cells to doxorubicin at least partially via inhibiting angiogenesis.

Cancer MedicineVol. 14(8)
Guangxi Medical University (CN)
Natural Science Foundation of Guangxi Zhuang Autonomous Region, National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 18%
Extracellular vesicles in disease
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.